Professional Documents
Culture Documents
RN Education on SCVO2
Definition
Shock is an imbalance between tissue oxygen supply and demand, resulting in inadequate tissue perfusion.
- Shock may be present in the face of a: high, low or normal blood pressure High or Low Cardiac Output (CO) High or Low Systemic Volume Resistance (SVR)
PERFUSION is crucial
Normal blood pressure may not equate to good flow
ARDS Adult Respiratory Distress Syndrome CA O2 Arterial Oxygen Content CO Cardiac Output EGDT Early Goal Directed Therapy
MAP Mean Arterial Pressure MODS Multi-organ Dysfunction Syndrome PAC Pulmonary Artery Catheter
ScvO2
SvO2 SIRS
SVR
TO2 VO2
Classification by Etiology
Cardiogenic
Myocardial Dysrrhythmia Congenital Heart Disease (Duct Dependent)
Hypovolemic
Hemorrhage Serum/Plasma loss Drugs
Distributive
Anaphylactic Neurogenic Septic
Obstructive
Pneumothorax, Tamponade, Dissection
Dissociative
Heat, CO, Cyanide Endocrine
Early Detection
Appropriate Disposition
Improved Outcomes
Mortality
Septic Shock 30% - 45% (1 month mortality) Cardiogenic 60% - 90% Hypovolemic 30% - 40%
Grater than 1 million cases of shock are seen in Emergency Departments annually
EGDT = Early Goal Directed Therapy
Pathophysiology
Oxygen supply and demand imbalance Conversion from aerobic to anaerobic metabolism
Cellular
Major third space fluid loss
Capillary Leak Fluid & Electrolyte Imbalance
Diarrhea, Sweat, Vomit
Pathophysiology
Vascular Hyporeactivity
Adrenocortical Disruption Decreased Response to Catecholamines
Pathophysiology
Resultant Systemic Physiology -Cell Death -End Organ Dysfunction
Physiology
Characterized by three stages
Preshock (warm shock, compensated shock, cryptogenic shock) Shock End organ dysfunction
Physiology
Compensated shock
Low preload shock tachycardia, vasoconstriction, mildly decreased BP Low afterload (distributive) shock peripheral vasodilatation, hyperdynamic state
Pathophysiology
Shock
Initial signs of end organ dysfunction Tachycardia Tachypnea Metabolic acidosis Oliguria Cool and clammy skin
Physiology
End Organ Dysfunction Progressive irreversible dysfunction Oliguria or anuria Progressive acidosis, CO Agitation, obtundation, coma Patient death
Shock Pathways
Distributive
Decreased SVR
Myocardial Dysfunction
Cardiogenic
Myocardial Damage
Obstructive
Pericardial Tamponade
Hypovolemic
Hemorrhage
Reduced Filling
Reduced Systolic Function
Reduced Preload
DEATH
Physical Examination
Vitals Temperature may be or normal. General Pale, Weak HEENT Dry Mucous Membranes, Pale Conjunctiva Neck Weak or Absent Carotid Pulses Cardiovascular Usually Tachycardia Late Bradycardia Exception Athletes, Beta-blockers, Intra-abdominal Hemorrhage Hypoglycemia Cardiovascular drugs
Physical Examination
Respiratory Tachypnea Dead Space Bronchospasm Adult Respiratory Distress Syndrome (ARDS) Abdomen ILEUS low flow state GI Bleed Pancreatitis Acute Cholecystitis Mesenteric Ischemia
Physical Examination
Extremities Pulses Look for effusions, tracks, infections, septic joints, line infection,
Physical Examination
GU Genitourinary (Trauma, Blood Loss) Oliguria Polyuria NeuroAltered Mental Status Cord Signs Loss of cardiac sympathetic tone Paralysis Meningismus Psyche Agitation
Obtundation
Hypovolemic Shock
Hypovolemic Shock is an acute intravascular volume loss Results from decreased preload
Etiology Hemorrhage, Trauma, GI Bleed, and Ruptured Aneurysm Fluid loss Burns, Diabetic Ketoacidosis Diabetic Insipidus, Vomiting, and Diarrhea
Cardiogenic Shock
Cardiogenic Shock is decreased cardiac output (CO) despite adequate volume.
Cardiogenic Shock
Etiology Myocardial Infarction Cardiomyopathy Dysrhythmia Mechanical CHF (Congestive Heart Failure) Valve Contusion Extra cardiac (obstructive)
Cardiogenic Shock
Artioventricular valves Tricuspid and Mitral
During diastole, the valves serve as a conduit from atria to ventricles
Cardiogenic Shock
Clinical features
Distended Neck Veins Weak or Absent Pulse Arrhythmia often Tachycardia Pulsus Paradoxus (if tamponade)
Distributive Shock
Distributive Shock is a metabolic derangement that impairs cellular respiration, due to severe decrease in SVR
Vasodilation reduces after load. May be found with cardiac output (CO).
Bacteremia
Pancreatiits
Infection
Fungemia
SEPSIS`
SIRS
Parisitemia
Trauma
Viremia
Other
Burns
Other
Bone et al Chest 1992
Septic Shock
Distributive Shock
Neurogenic / High Spinal Loss of cardiac sympathetic tone Heart rate Vascular dilitation Warm skin
Distributive Shock
Systemic Inflammation Pancreatitis Burns Biliary
Toxic Shock Syndrome
Distributive Shock
Anaphylaxis & Anaphylactoid (Know the difference) Widespread vasodilatation due to release of histamine. Endocrine Addisonian Myxedema
Anaphylactoid
No prior exposure necessary No IgE antibody involved Common reaction to invenomations/insect, Nuts, Shell fish, Pharmaceuticals, Latex
Anaphylaxis
Vasodilatation Increased vascular permeability Bronchoconstriction Increased mucus production Increased inflammatory mediators recruitment to sites of antigen interaction
Anaphylaxis
Clinic Presentation
Immediate response Cutaneous manifestations
urticaria, erythema, pruritis, angioedema
Respiratory compromise
stridor, wheezing, bronchorrhea, resp. distress
Circulatory collapse
tachycardia, vasodilation, hypotension
Obstructive Shock
Obstructive Shock is extra cardiac obstruction to blood flow.
Tension pneumothorax Cardiac tamponade Pulmonary embolus Aortic stenosis
Dissociative Shock
Heat
Carbon Monoxide Cyanide Endocrine
Evaluation
Simultaneous differential diagnosis thinking occurs in tandem with your treatment. Targeted History & Physical What type(s) of shock am I dealing with?
Full Laboratory Protocols & Evaluation What would you order? (dont forget pregnancy) What Cultures would you obtain?
Evaluation
Other Studies / Imaging
EKG = Electrocardiogram) FAST = Focused Assessment with Sonography in Trauma CT = Computerized Tomography ECHO = Echocardiogram LP = Lumbar Puncture (if appropriate)
Evaluation
Monitoring Vital signs including capnography Urine output CVP Central Venous Pressure Rectal probe Arterial line Pulmonary Artery (PA) catheterization
Does the patient arrive with any preexisting lines that may be infected.
Up to 30% of shock patients can have adrenal insufficiency
References
Dellinger R, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32(3): 858-873. Dellinger R, Levy M, Carlet J, et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 2008;36(1):296-327. Morris E, Light RB, Garber GE. Identifying patients with severe sepsis who should not be treated with drotrecogin alfa (activated). Am J Surgery 2002; 184: 19S-24S. Nguygen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004: 32(8): 1637-1642) Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345(19):13681377. Ruble, Cheryl RN, MICN, Alameida, Rich MD. Sepsis Workshop. 2011. Mills/Pensula Medical Center Sherwin RL, M.D. Shock. Wayne State University. July 18th 2006. Presentation Tintinalli JE. Tintinallis Emergency Medicine, A comprehensive Study Guide 7th ed. McGrawHill Med 2011. (165-182, 222-240, 1003-1014) Vanhorebeek I, Van den Berghe G. The neuroendocrine response to critical illness is a dynamic process. Crit Care Clin 2006; 22: 1-15.